HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 18-SEP-09 3JWC TITLE CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE TITLE 2 REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO-5-(3-(3,4,5- TITLE 3 TRIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS ANTHRACIS; SOURCE 3 ORGANISM_TAXID: 1392; SOURCE 4 GENE: BAS2083, BA_2237, DFRA, GBAA2237, GBAA_2237; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: M15; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PQE2 KEYWDS OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.C.ANDERSON,J.M.BEIERLEIN,N.G.KARRI REVDAT 4 06-SEP-23 3JWC 1 REMARK REVDAT 3 13-OCT-21 3JWC 1 REMARK SEQADV REVDAT 2 20-NOV-13 3JWC 1 HET HETATM HETNAM REMARK REVDAT 2 2 1 SITE VERSN HEADER REVDAT 1 29-SEP-10 3JWC 0 JRNL AUTH J.M.BEIERLEIN,N.G.KARRI,A.C.ANDERSON JRNL TITL TARGETED MUTATIONS IN BACILLUS ANTHRACIS DIHYDROFOLATE JRNL TITL 2 REDUCTASE CONDENSE COMPLEX STRUCTURE-ACTIVITY RELATIONSHIPS JRNL REF J.MED.CHEM. 2010 JRNL REFN ISSN 0022-2623 REMARK 2 REMARK 2 RESOLUTION. 2.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 12210 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 628 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.57 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 867 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.50 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 43 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2758 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 146 REMARK 3 SOLVENT ATOMS : 116 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 2.445 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.299 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.207 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.869 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2994 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4064 ; 1.296 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 328 ; 5.654 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 154 ;34.523 ;23.896 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 492 ;17.805 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;17.227 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 406 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2296 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1257 ; 0.184 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1970 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 160 ; 0.149 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 33 ; 0.221 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.151 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1681 ; 0.485 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2668 ; 0.897 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1548 ; 1.015 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1396 ; 1.728 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 162 3 REMARK 3 1 B 1 B 162 3 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 647 ; 0.03 ; 0.05 REMARK 3 LOOSE POSITIONAL 1 A (A): 694 ; 0.51 ; 5.00 REMARK 3 TIGHT THERMAL 1 A (A**2): 647 ; 0.06 ; 0.50 REMARK 3 LOOSE THERMAL 1 A (A**2): 694 ; 0.83 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3JWC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000055241. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 77.2 REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.080900 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12210 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 42.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.11400 REMARK 200 R SYM (I) : 0.11400 REMARK 200 FOR THE DATA SET : 19.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.39100 REMARK 200 R SYM FOR SHELL (I) : 0.39100 REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3EOB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: INITIALLY GROWN IN 25% PEG 10000, 0.1 REMARK 280 M MES. MACROSEEDING IN 10% PEG 10000, 0.1 M MES, PH 6.75, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z+1/2 REMARK 290 4555 Y,-X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.55000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.55000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EKB A 208 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EKB B 208 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3EOB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH REMARK 900 LFA-1 I DOMAIN, FORM II REMARK 900 RELATED ID: 3JVX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE REMARK 900 COMPLEXED WITH NADPH AND 2,4-DIAMINO-5-(3-(3,4,5-TRIMETHOXYPHENYL) REMARK 900 PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A) REMARK 900 RELATED ID: 3JW3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (F96I) DIHYDROFOLATE REMARK 900 REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM REMARK 900 RELATED ID: 3JW5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REMARK 900 REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM REMARK 900 RELATED ID: 3JWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REMARK 900 REDUCTASE COMPLEXED WITH NADPH AND (R)-2,4-DIAMINO-5-(3-HYDROXY-3- REMARK 900 (3,4,5-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP113A) REMARK 900 RELATED ID: 3JWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REMARK 900 REDUCTASE COMPLEXED WITH NADPH AND (S)-2,4-DIAMINO-5-(3-METHOXY-3- REMARK 900 (3,4,5-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A) REMARK 900 RELATED ID: 3JWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE REMARK 900 COMPLEXED WITH NADPH AND (S)-2,4-DIAMINO-5-(3-METHOXY-3-(3,4,5- REMARK 900 TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A) DBREF 3JWC A 1 162 UNP Q81R22 Q81R22_BACAN 1 162 DBREF 3JWC B 1 162 UNP Q81R22 Q81R22_BACAN 1 162 SEQADV 3JWC HIS A -5 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS A -4 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS A -3 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS A -2 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS A -1 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS A 0 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC ARG A 2 UNP Q81R22 ILE 2 ENGINEERED MUTATION SEQADV 3JWC PHE A 102 UNP Q81R22 TYR 102 ENGINEERED MUTATION SEQADV 3JWC HIS B -5 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS B -4 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS B -3 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS B -2 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS B -1 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC HIS B 0 UNP Q81R22 EXPRESSION TAG SEQADV 3JWC ARG B 2 UNP Q81R22 ILE 2 ENGINEERED MUTATION SEQADV 3JWC PHE B 102 UNP Q81R22 TYR 102 ENGINEERED MUTATION SEQRES 1 A 168 HIS HIS HIS HIS HIS HIS MET ARG VAL SER PHE MET VAL SEQRES 2 A 168 ALA MET ASP GLU ASN ARG VAL ILE GLY LYS ASP ASN ASN SEQRES 3 A 168 LEU PRO TRP ARG LEU PRO SER GLU LEU GLN TYR VAL LYS SEQRES 4 A 168 LYS THR THR MET GLY HIS PRO LEU ILE MET GLY ARG LYS SEQRES 5 A 168 ASN TYR GLU ALA ILE GLY ARG PRO LEU PRO GLY ARG ARG SEQRES 6 A 168 ASN ILE ILE VAL THR ARG ASN GLU GLY TYR HIS VAL GLU SEQRES 7 A 168 GLY CYS GLU VAL ALA HIS SER VAL GLU GLU VAL PHE GLU SEQRES 8 A 168 LEU CYS LYS ASN GLU GLU GLU ILE PHE ILE PHE GLY GLY SEQRES 9 A 168 ALA GLN ILE PHE ASP LEU PHE LEU PRO TYR VAL ASP LYS SEQRES 10 A 168 LEU TYR ILE THR LYS ILE HIS HIS ALA PHE GLU GLY ASP SEQRES 11 A 168 THR PHE PHE PRO GLU MET ASP MET THR ASN TRP LYS GLU SEQRES 12 A 168 VAL PHE VAL GLU LYS GLY LEU THR ASP GLU LYS ASN PRO SEQRES 13 A 168 TYR THR TYR TYR TYR HIS VAL TYR GLU LYS GLN GLN SEQRES 1 B 168 HIS HIS HIS HIS HIS HIS MET ARG VAL SER PHE MET VAL SEQRES 2 B 168 ALA MET ASP GLU ASN ARG VAL ILE GLY LYS ASP ASN ASN SEQRES 3 B 168 LEU PRO TRP ARG LEU PRO SER GLU LEU GLN TYR VAL LYS SEQRES 4 B 168 LYS THR THR MET GLY HIS PRO LEU ILE MET GLY ARG LYS SEQRES 5 B 168 ASN TYR GLU ALA ILE GLY ARG PRO LEU PRO GLY ARG ARG SEQRES 6 B 168 ASN ILE ILE VAL THR ARG ASN GLU GLY TYR HIS VAL GLU SEQRES 7 B 168 GLY CYS GLU VAL ALA HIS SER VAL GLU GLU VAL PHE GLU SEQRES 8 B 168 LEU CYS LYS ASN GLU GLU GLU ILE PHE ILE PHE GLY GLY SEQRES 9 B 168 ALA GLN ILE PHE ASP LEU PHE LEU PRO TYR VAL ASP LYS SEQRES 10 B 168 LEU TYR ILE THR LYS ILE HIS HIS ALA PHE GLU GLY ASP SEQRES 11 B 168 THR PHE PHE PRO GLU MET ASP MET THR ASN TRP LYS GLU SEQRES 12 B 168 VAL PHE VAL GLU LYS GLY LEU THR ASP GLU LYS ASN PRO SEQRES 13 B 168 TYR THR TYR TYR TYR HIS VAL TYR GLU LYS GLN GLN HET NDP A 207 48 HET EKB A 208 25 HET NDP B 207 48 HET EKB B 208 25 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM EKB 6-ETHYL-5-[3-(3,4,5-TRIMETHOXYPHENYL)PROP-1-YN-1- HETNAM 2 EKB YL]PYRIMIDINE-2,4-DIAMINE FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 EKB 2(C18 H22 N4 O3) FORMUL 7 HOH *116(H2 O) HELIX 1 1 LEU A 25 MET A 37 1 13 HELIX 2 2 ARG A 45 GLY A 52 1 8 HELIX 3 3 SER A 79 CYS A 87 1 9 HELIX 4 4 GLY A 98 LEU A 106 1 9 HELIX 5 5 PRO A 107 VAL A 109 5 3 HELIX 6 6 LEU B 25 MET B 37 1 13 HELIX 7 7 ARG B 45 GLY B 52 1 8 HELIX 8 8 SER B 79 CYS B 87 1 9 HELIX 9 9 GLY B 98 LEU B 106 1 9 HELIX 10 10 PRO B 107 VAL B 109 5 3 SHEET 1 A16 GLU A 75 ALA A 77 0 SHEET 2 A16 ASN A 60 VAL A 63 1 N ASN A 60 O GLU A 75 SHEET 3 A16 LEU A 41 GLY A 44 1 N MET A 43 O ILE A 61 SHEET 4 A16 GLU A 92 GLY A 97 1 O GLY A 97 N GLY A 44 SHEET 5 A16 ARG A 2 ASP A 10 1 N SER A 4 O ILE A 95 SHEET 6 A16 LYS A 111 ILE A 117 1 O TYR A 113 N PHE A 5 SHEET 7 A16 TYR A 153 LYS A 160 -1 O TYR A 158 N LEU A 112 SHEET 8 A16 TRP A 135 LYS A 142 -1 N VAL A 138 O VAL A 157 SHEET 9 A16 TRP B 135 LYS B 142 1 O VAL B 140 N GLU A 137 SHEET 10 A16 TYR B 153 LYS B 160 -1 O TYR B 155 N GLU B 141 SHEET 11 A16 LYS B 111 ILE B 117 -1 N LYS B 116 O TYR B 154 SHEET 12 A16 ARG B 2 ASP B 10 1 N PHE B 5 O TYR B 113 SHEET 13 A16 GLU B 92 GLY B 97 1 O ILE B 95 N SER B 4 SHEET 14 A16 LEU B 41 GLY B 44 1 N ILE B 42 O PHE B 94 SHEET 15 A16 ASN B 60 VAL B 63 1 O ILE B 61 N LEU B 41 SHEET 16 A16 GLU B 75 ALA B 77 1 O GLU B 75 N ASN B 60 SHEET 1 B 2 VAL A 14 GLY A 16 0 SHEET 2 B 2 THR A 125 PHE A 126 -1 O THR A 125 N ILE A 15 SHEET 1 C 2 VAL B 14 GLY B 16 0 SHEET 2 C 2 THR B 125 PHE B 126 -1 O THR B 125 N ILE B 15 CISPEP 1 GLY A 97 GLY A 98 0 0.85 CISPEP 2 GLY B 97 GLY B 98 0 4.15 SITE 1 AC1 27 VAL A 7 ALA A 8 ILE A 15 GLY A 16 SITE 2 AC1 27 ASN A 19 ASN A 20 LEU A 21 GLY A 44 SITE 3 AC1 27 ARG A 45 LYS A 46 ASN A 47 VAL A 63 SITE 4 AC1 27 THR A 64 ARG A 65 HIS A 78 PHE A 96 SITE 5 AC1 27 GLY A 97 GLY A 98 ALA A 99 GLN A 100 SITE 6 AC1 27 ILE A 101 LEU A 104 THR A 125 HOH A 164 SITE 7 AC1 27 HOH A 167 EKB A 208 HOH A 217 SITE 1 AC2 12 MET A 6 VAL A 7 ALA A 8 ASN A 20 SITE 2 AC2 12 LEU A 21 GLU A 28 VAL A 32 ASN A 47 SITE 3 AC2 12 ILE A 51 PHE A 96 THR A 115 NDP A 207 SITE 1 AC3 29 VAL B 7 ALA B 8 ILE B 15 GLY B 16 SITE 2 AC3 29 ASN B 19 ASN B 20 LEU B 21 TRP B 23 SITE 3 AC3 29 GLY B 44 ARG B 45 LYS B 46 ASN B 47 SITE 4 AC3 29 VAL B 63 THR B 64 ARG B 65 HIS B 78 SITE 5 AC3 29 PHE B 96 GLY B 97 GLY B 98 ALA B 99 SITE 6 AC3 29 GLN B 100 ILE B 101 LEU B 104 HOH B 163 SITE 7 AC3 29 HOH B 170 HOH B 180 HOH B 185 EKB B 208 SITE 8 AC3 29 HOH B 210 SITE 1 AC4 10 MET B 6 VAL B 7 ALA B 8 TRP B 23 SITE 2 AC4 10 GLU B 28 VAL B 32 ASN B 47 ILE B 51 SITE 3 AC4 10 PHE B 96 NDP B 207 CRYST1 77.845 77.845 67.100 90.00 90.00 90.00 P 42 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012846 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012846 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014903 0.00000